One of Canada’s major banks is placing bets that Canadians will be spending more on recreational cannabis than on liquor by 2020.

Canadian Imperial Bank of Commerce (CIBC) released a report this week that provided predictions of the recreational Canadian cannabis consumption, which it estimated would reach 800,000 kilograms over the next two years.


“We believe that by 2020, the legal market for adult-use cannabis will approach C$6.5 billion in retail sales,” the report said. “For context, this is greater than the amount of spirits sold in this country, and approaches wine in scale.”

Canada’s federal government is currently on track to legalizing sales and possession of marijuana, with implementation plans set for later this year. The report elaborated by saying that provinces would see the most benefits from cannabis sales, estimating over C$3 billion in generated income.

“Public revenue-generating opportunities like this come along once in a lifetime, and though provinces may claim otherwise, they are the big winners of legalization,” the report read. “We estimate that provincial governments will capture a stunning 70 [percent] of industry profits.”

Comparatively, CIBC sees private firms generating almost C$1 billion in earnings before interest, taxes, depreciation, and amortization (EBITDA) as “part of the shadow economy becomes legitimate business.”

On the medical side, Canadians currently consume around 60,000 kilograms of marijuana each year. However, that number has nothing on illicit sales of cannabis, the report says, referring to the former comparatively as a “drop in the bucket”.

Incorporating information from Statistics Canada, the report touched on demand by detailing that just less than 5 million Canadians spent around C$5.7 billion on cannabis in 2017 for both medical and recreational purposes. While still trailing behind the C$16 billion spent on tobacco and the C$7 billion spent on wine, cannabis expenditure topped the C$5.1 billion spent on spirits last year — all while still being considered an illegal substance.

The numbers also suggested that usage among Canadians has grown by 5 percent each year since the early ’60s.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Olivia Da Silva, hold no direct investment interest in any company mentioned in this article.

 Sweet Earth Holdings Corp. (CSE: SE) (FSE: 1KZ1) (OTCQB: SEHCF) (“Sweet Earth” the “Company”) is pleased to announce that it has received full Depository Trust Company (“DTC”) eligibility in the United States. On October 20, 2020, Sweet Earth announced that its shares had been listed on the United States’ Over-The-Counter Bulletin (“OTCQB”) under the ticker SEHCF.

DTC status means that Sweet Earth shares are now eligible to be transferred between brokerage accounts within the United States and significantly augments the ease in which American-based investors are able to trade Sweet Earth shares.

Keep reading... Show less

Hill Street Beverage Company Inc. (TSXV: BEER) (“Hill Street” or the “Company”), announces that further to its press releases dated July 21, 2020 and July 31, 2020, the Company proposes to amend the exercise price of 19,405,804 warrants of the Company that were originally issued on July 27, 2018, to $0.10. These warrants are set to expire on December 31, 2020.

The Company had initially proposed a lower amended price, but that proposal was not approved by the TSX Venture Exchange (“Exchange“), however, the Exchange indicated that a $0.10 exercise price, may be more acceptable. Accordingly, the proposed amendment remains subject to Exchange approval.

Keep reading... Show less

Issuance of U.S. Patent No. 10,851,077 covering methods for extracting and concentrating cannabinoids using ultrasound-enhanced solvent extraction bolsters World Class’ intellectual patent portfolio

World-Class Extractions Inc. (CSE:PUMP)(FRA:WCF)(OTCQB:WCEXF) (the “Company” or “World-Class”) is pleased to announced the United States Patent and Trademark Office (“USPTO”) has issued U.S. Patent No. 10,851,077 on December 1, 2020 in relation to the Company’s methods for extracting and concentrating cannabinoids and other target compounds from cannabis using ultrasound-enhanced solvent extraction

Keep reading... Show less

Ubican brings well-known brands and is a trusted vendor with an established sales and marketing program

Chemesis International Inc. (CSE:CSI) (OTCQB:CADMF) (FRA:CWAA) (the “Company” or “Chemesis”), announces Ubican Global (“Ubican”) as its primary supplier for its United States VICKI program. Ubican is a trusted supplier of a family of brands, each with multiple types of products. The products include tinctures, digestibles, edibles, pet, beautyskincare, topical, edible, fitness, and smokable products

Keep reading... Show less

 Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) is pleased to announce that it has engaged VisionWorks Engineering of San Diego, CA to commence engineering work to complete and test a proof of concept prototype of its nasal mist device.

This is a major milestone towards the ultimate goal for development of effective delivery methods and commercialization. The Company holds several provisional patent applications including for a nasal mist device entitled “Device and Method for the Treatment of Traumatic Brain Injuries and Post-Traumatic Stress Disorder”. This device includes a nasal delivery system for administration of pharmaceutical agents such as a psilocybin-derived agent and/or N-acetylcysteine (“NAC“) at preselected dosages and times. The device design allows for the precise control and delivery of medicines through the nasal cavity for faster and more efficient uptake of psychedelics and other medicines that target the brain.

Keep reading... Show less